[Psychiatric disorders and somatic pathologies].
Over recent decades significant advances have been made in the treatment of patients with serious psychiatric illnesses such as schizophrenia or mood disorders. These advances result from the use of new molecules and especially biopsychosocial treatments drawing on multidisciplinarity and networking. Supporting the somatic treatment of patients is one of the major challenges for improving psychiatric care.